FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, in particular to an (N-substituted imidazole)-carboxylic acid ester chiral compound containing an ether side chain of formula (I) and a pharmaceutically acceptable salt thereof. Invention also relates to a process for the preparation of a compound of formula (I), a pharmaceutically acceptable salt thereof and use thereof.
EFFECT: technical result: an ester chiral compound is obtained useful in the preparation of drugs inhibiting the central nervous system, which can cause sedative, hypnotic and/or anesthetic effects.
9 cl, 3 dwg, 4 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
ETOMIDATE ANALOGUES WITH IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES | 2009 |
|
RU2540116C2 |
SUBSTITUTED IMIDAZOLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND A PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2099330C1 |
NOVEL COMPOUNDS OF REVERSE TURN MIMETICS, METHOD OF THEIR MANUFACTURING AND APPLICATION | 2010 |
|
RU2515983C2 |
HYDROQUINONE COMPOUNDS, METHODS FOR PREPARING THEREOF AND USE IN ANTI-TUMOUR OR IMMUNOMODULATORY THERAPY | 2017 |
|
RU2708464C2 |
LIGANDS OF THYROID RECEPTORS: DERIVATIVES OF ANILINE | 2001 |
|
RU2260586C2 |
PAN-GENOMIC INHIBITORS OF THE HEPATITIS C VIRUS PROTEIN NS5A, PHARMACEUTICAL COMPOSITIONS, INTERMEDIATES FOR THE SYNTHESIS OF INHIBITORS, AND METHODS FOR THEIR PREPARATION AND USE | 2016 |
|
RU2669919C1 |
CALPAIN MODULATORS AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773288C2 |
COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2581367C2 |
METHOD OF SYNTHESISING DERIVATIVES OF AMINO-METHYL TETRALIN | 2009 |
|
RU2512285C2 |
METHODS OF THERAPY BY APPLYING THE COMPOUNDS EITHER OF SPECIFIC OR SELECTIVE ACTIVITY TO RETINAL ACID RECEPTOR RAR | 1996 |
|
RU2191009C2 |
Authors
Dates
2018-07-04—Published
2014-10-30—Filed